Erythropoietin Use in Cancer Patients: A Matter of Life and Death?

This publication has 19 references indexed in Scilit:

• Recombinant human erythropoietin in cancer-related anemia: an evidence-based review
  Best Practice & Research Clinical Haematology, 2005
• Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
  Journal of Clinical Oncology, 2005
• The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
  European Journal Of Cancer, 2004
• Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials
  JNCI Journal of the National Cancer Institute, 2001
• Anemia as an independent prognostic factor for survival in patients with cancer
  Cancer, 2001
• Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
  Journal of Clinical Oncology, 2001
• Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing
  Journal of Clinical Oncology, 2001
• Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
  Journal of Clinical Oncology, 1998
• Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
  Journal of Clinical Oncology, 1997
• Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
  New England Journal of Medicine, 1990